The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism
Status:
COMPLETED
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The purpose of our research is to clarify the therapeutic efficacy and safety of Finerenone in patients with Primary Aldosteronism and explore the effective clinical predictive indicators of Finerenone in the treatment of Primary Aldosteronism.
Phase:
PHASE4
Details
Lead Sponsor:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School